Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y; Quebec Clostridium difficile Infection Surveillance Program (QCISP).

Am J Infect Control. 2017 May 23. pii: S0196-6553(17)30294-8. doi: 10.1016/j.ajic.2017.04.002. [Epub ahead of print]

PMID:
28549882
2.

Impact of Therapy on Recovery during Rehabilitation in Patients with Traumatic Spinal Cord Injury.

Truchon C, Fallah N, Santos A, Vachon J, Noonan VK, Cheng CL.

J Neurotrauma. 2017 Jun 26. doi: 10.1089/neu.2016.4932. [Epub ahead of print]

PMID:
28493787
3.

Measuring positive mental health in Canada: construct validation of the Mental Health Continuum-Short Form.

Orpana H, Vachon J, Dykxhoorn J, Jayaraman G.

Health Promot Chronic Dis Prev Can. 2017 Apr;37(4):123-130. doi: 10.24095/hpcdp.37.4.03. English, French.

4.

Effect of Cue Timing and Modality on Gait Initiation in Parkinson Disease With Freezing of Gait.

Lu C, Amundsen Huffmaster SL, Tuite PJ, Vachon JM, MacKinnon CD.

Arch Phys Med Rehabil. 2017 Jul;98(7):1291-1299.e1. doi: 10.1016/j.apmr.2017.01.009. Epub 2017 Feb 4.

PMID:
28167093
5.

Barriers to the use of toxicogenomics data in human health risk assessment: A survey of Canadian risk assessors.

Vachon J, Campagna C, Rodriguez MJ, Sirard MA, Levallois P.

Regul Toxicol Pharmacol. 2017 Apr;85:119-123. doi: 10.1016/j.yrtph.2017.01.008. Epub 2017 Jan 27.

PMID:
28137640
6.

Correlates of well-being among Canadians with mood and/or anxiety disorders.

Orpana H, Vachon J, Pearson C, Elliott K, Smith M, Branchard B.

Health Promot Chronic Dis Prev Can. 2016 Dec;36(12):302-313. English, French.

7.

Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period.

Roth VR, Mitchell R, Vachon J, Alexandre S, Amaratunga K, Smith S, Vearncombe M, Davis I, Mertz D, Henderson E, John M, Johnston L, Lemieux C, Pelude L, Gravel D; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2017 Feb;38(2):147-153. doi: 10.1017/ice.2016.256. Epub 2016 Nov 11.

PMID:
27834161
8.

Match of Solubility Parameters Between Oil and Surfactants as a Rational Approach for the Formulation of Microemulsion with a High Dispersed Volume of Copaiba Oil and Low Surfactant Content.

Xavier-Junior FH, Huang N, Vachon JJ, Rehder VL, do Egito ES, Vauthier C.

Pharm Res. 2016 Dec;33(12):3031-3043. Epub 2016 Sep 6.

PMID:
27599989
9.

Describing the population health burden of depression: health-adjusted life expectancy by depression status in Canada.

Steensma C, Loukine L, Orpana H, McRae L, Vachon J, Mo F, Boileau-Falardeau M, Reid C, Choi BC.

Health Promot Chronic Dis Prev Can. 2016 Oct;36(10):205-213. English, French.

10.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794. doi: 10.1128/AAC.01359-16. Print 2016 Nov.

11.

Serial multiple crossed immunoelectrophoresis at a microscale: A stamp-sized 2D immunoanalysis of protein C3 activation caused by nanoparticles.

Coty JB, Varenne F, Vachon JJ, Vauthier C.

Electrophoresis. 2016 Sep;37(17-18):2401-9. doi: 10.1002/elps.201500572. Epub 2016 Aug 9.

PMID:
27387591
12.

Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression.

Comai S, Bertazzo A, Vachon J, Daigle M, Toupin J, Côté G, Turecki G, Gobbi G.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:8-16. doi: 10.1016/j.pnpbp.2016.04.012. Epub 2016 Apr 23.

PMID:
27117820
13.

Monitoring positive mental health and its determinants in Canada: the development of the Positive Mental Health Surveillance Indicator Framework.

Orpana H, Vachon J, Dykxhoorn J, McRae L, Jayaraman G.

Health Promot Chronic Dis Prev Can. 2016 Jan;36(1):1-10. Review. English, French.

14.

Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.

Schmidt B, Roberts RS, Davis PG, Doyle LW, Asztalos EV, Opie G, Bairam A, Solimano A, Arnon S, Sauve RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators.

J Pediatr. 2015 Nov;167(5):982-6.e2. doi: 10.1016/j.jpeds.2015.07.067. Epub 2015 Aug 28.

PMID:
26318030
15.

Predicting severe motor impairment in preterm children at age 5 years.

Synnes A, Anderson PJ, Grunau RE, Dewey D, Moddemann D, Tin W, Davis PG, Doyle LW, Foster G, Khairy M, Nwaesei C, Schmidt B; CAP Trial Investigator group.

Arch Dis Child. 2015 Aug;100(8):748-53. doi: 10.1136/archdischild-2014-307695. Epub 2015 Mar 17.

PMID:
25784749
16.

Social variables predict gains in cognitive scores across the preschool years in children with birth weights 500 to 1250 grams.

Manley BJ, Roberts RS, Doyle LW, Schmidt B, Anderson PJ, Barrington KJ, Böhm B, Golan A, van Wassenaer-Leemhuis AG, Davis PG; Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators.

J Pediatr. 2015 Apr;166(4):870-6.e1-2. doi: 10.1016/j.jpeds.2014.12.016. Epub 2015 Jan 29.

PMID:
25641237
17.

Male inmate profiles and their biological correlates.

Horn M, Potvin S, Allaire JF, Côté G, Gobbi G, Benkirane K, Vachon J, Dumais A.

Can J Psychiatry. 2014 Aug;59(8):441-9.

18.

Reduction in developmental coordination disorder with neonatal caffeine therapy.

Doyle LW, Schmidt B, Anderson PJ, Davis PG, Moddemann D, Grunau RE, O'Brien K, Sankaran K, Herlenius E, Roberts R; Caffeine for Apnea of Prematurity Trial investigators.

J Pediatr. 2014 Aug;165(2):356-359.e2. doi: 10.1016/j.jpeds.2014.04.016. Epub 2014 May 17.

PMID:
24840756
19.

Comparison of cognitive functioning among individuals with treated restless legs syndrome (RLS), untreated RLS, and no RLS.

Lee HB, Ramsey CM, Spira AP, Vachon J, Allen R, Munro CA.

J Neuropsychiatry Clin Neurosci. 2014 Winter;26(1):87-91. doi: 10.1176/appi.neuropsych.12120394.

PMID:
24515680
20.

An ultrafast surface-bound photo-active molecular motor.

Vachon J, Carroll GT, Pollard MM, Mes EM, Brouwer AM, Feringa BL.

Photochem Photobiol Sci. 2014 Feb;13(2):241-6. doi: 10.1039/c3pp50208b.

PMID:
24096390

Supplemental Content

Loading ...
Support Center